Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Bevacizumab”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Testing effectiveness (Phase 2)UnknownNCT01321775
What this trial is testing

Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast Cancer

Who this might be right for
Breast Cancer
Hospital Universitario Madrid Sanchinarro 44
Large-scale testing (Phase 3)Study completedNCT02901236
What this trial is testing

Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma

Who this might be right for
Glaucoma
Athens Vision Eye Institute 40
Testing effectiveness (Phase 2)Study completedNCT00308516
What this trial is testing

5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer

Who this might be right for
Rectal CancerCancer of the RectumColorectal Cancer
SCRI Development Innovations, LLC 66
Testing effectiveness (Phase 2)Study completedNCT02717962
What this trial is testing

Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

Who this might be right for
GliomaGlioblastomaGlioblastoma Multiforme+2 more
Kintara Therapeutics, Inc. 118
Large-scale testing (Phase 3)Study completedNCT00884741
What this trial is testing

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaSupratentorial Glioblastoma
National Cancer Institute (NCI) 637
Not applicableActive Not RecruitingNCT06515678
What this trial is testing

Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

Who this might be right for
Ovarian CancerAntiangiogenic-Associated HypertensionAdjuvant Bevacizumab+1 more
Groupe Hospitalier Pitie-Salpetriere 9,464
Testing effectiveness (Phase 2)Ended earlyNCT00924209
What this trial is testing

A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

Who this might be right for
NSCLCStage IIIA (N2)
National Cancer Institute (NCI) 7
Large-scale testing (Phase 3)Study completedNCT00112918
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 3,451
Testing effectiveness (Phase 2)Study completedNCT00365365
What this trial is testing

Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 214
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07328802
What this trial is testing

Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma

Who this might be right for
ORR,OS,PFS
Second Affiliated Hospital, School of Medicine, Zhejiang University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018947
What this trial is testing

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

Who this might be right for
Resectable Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 90
Testing effectiveness (Phase 2)Looking for participantsNCT04727307
What this trial is testing

Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Montpellier 202
Testing effectiveness (Phase 2)UnknownNCT05341193
What this trial is testing

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Ended earlyNCT00925652
What this trial is testing

Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 55
Testing effectiveness (Phase 2)Study completedNCT00621049
What this trial is testing

Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
SCRI Development Innovations, LLC 112
Testing effectiveness (Phase 2)Study completedNCT01102595
What this trial is testing

Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma

Who this might be right for
Glioblastomas
Grupo Español de Investigación en Neurooncología 102
Not applicableActive Not RecruitingNCT07009470
What this trial is testing

A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence

Who this might be right for
HCC
Tongji Hospital 130
Testing effectiveness (Phase 2)Looking for participantsNCT07239245
What this trial is testing

Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo

Who this might be right for
Resectable Hepatocellular Carcinoma With High Risk of Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Early research (Phase 1)Study completedNCT00079430
What this trial is testing

Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+9 more
National Cancer Institute (NCI) 113
Large-scale testing (Phase 3)Active Not RecruitingNCT03847428
What this trial is testing

Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 908
Load More Results